392
Views
14
CrossRef citations to date
0
Altmetric
Review

Stiripentol and vigabatrin current roles in the treatment of epilepsy

Pages 1091-1101 | Received 22 Oct 2015, Accepted 29 Feb 2016, Published online: 17 Mar 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Alejandra Vasquez, Elaine C Wirrell & Paul E Youssef. (2023) Stiripentol for the treatment of seizures associated with Dravet syndrome in patients 6 months and older and taking clobazam. Expert Review of Neurotherapeutics 23:4, pages 297-309.
Read now
Catherine Chiron. (2019) Stiripentol for the treatment of seizures associated with Dravet syndrome. Expert Review of Neurotherapeutics 19:4, pages 301-310.
Read now
Alan Talevi. (2016) Computational approaches for innovative antiepileptic drug discovery. Expert Opinion on Drug Discovery 11:10, pages 1001-1016.
Read now

Articles from other publishers (11)

Isabelle Boothman, Lisa M. Clayton, Mark McCormack, Alexandra McKibben Driscoll, Remi Stevelink, Patrick Moloney, Roland Krause, Wolfram S. Kunz, Sarah Diehl, Terence J. O’Brien, Graeme J. Sills, Gerrit-Jan de Haan, Federico Zara, Bobby P. Koeleman, Chantal Depondt, Anthony G. Marson, Hreinn Stefansson, Kari Stefansson, John Craig, Michael R. Johnson, Pasquale Striano, Holger Lerche, Simon J. Furney, Norman Delanty, EpiPGX Consortium, Sanjay M. Sisodiya & Gianpiero L. Cavalleri. (2023) Testing for pharmacogenomic predictors of ppRNFL thinning in individuals exposed to vigabatrin. Frontiers in Neuroscience 17.
Crossref
Shengying Lou & Sunliang Cui. (2022) Drug Treatment of Epilepsy: From Serendipitous Discovery to Evolutionary Mechanisms. Current Medicinal Chemistry 29:19, pages 3366-3391.
Crossref
Bruno Charlier, Albino Coglianese, Federica De Rosa, Ugo de Grazia, Francesca Felicia Operto, Giangennaro Coppola, Amelia Filippelli, Fabrizio Dal Piaz & Viviana Izzo. (2021) The Effect of Plasma Protein Binding on the Therapeutic Monitoring of Antiseizure Medications. Pharmaceutics 13:8, pages 1208.
Crossref
Dana C. Walters, Erwin E.W. Jansen, Gajja S. Salomons, Erland Arning, Paula Ashcraft, Teodoro Bottiglieri, Jean-Baptiste Roullet & K. Michael Gibson. (2021) Preferential accumulation of the active S-(+) isomer in murine retina highlights novel mechanisms of vigabatrin-associated retinal toxicity. Epilepsy Research 170, pages 106536.
Crossref
Petr Tůma, Tomáš Hložek, Blanka Sommerová & Dušan Koval. (2021) Large volume sample stacking of antiepileptic drugs in counter current electrophoresis performed in PAMAPTAC coated capillary. Talanta 221, pages 121626.
Crossref
James E. Frampton. (2019) Stiripentol: A Review in Dravet Syndrome. Drugs 79:16, pages 1785-1796.
Crossref
Rod Foroozan. (2018) Vigabatrin: Lessons Learned From the United States Experience. Journal of Neuro-Ophthalmology 38:4, pages 442-450.
Crossref
Catherine Chiron. (2018) Long‐term pragmatic use of stiripentol for Dravet syndrome. Developmental Medicine & Child Neurology 60:6, pages 535-535.
Crossref
Adriana Ulate-Campos & Ivan Sánchez Fernández. (2017) Cognitive and Behavioral Comorbidities: An Unwanted Effect of Antiepileptic Drugs in Children. Seminars in Pediatric Neurology 24:4, pages 320-330.
Crossref
Pierre-Antoine Nocquet, Sylvain Henrion, Aurélie Macé, Bertrand Carboni, Jose Manuel Villalgordo & François Carreaux. (2017) The Allyl Cyanate/Isocyanate Rearrangement: An Efficient Tool for the Stereocontrolled Formation of Allylic C-N Bonds. European Journal of Organic Chemistry 2017:10, pages 1295-1307.
Crossref
Shery Jacob & Anroop B. Nair. (2016) An Updated Overview on Therapeutic Drug Monitoring of Recent Antiepileptic Drugs. Drugs in R&D 16:4, pages 303-316.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.